Person

Marlene Debel

EVP & Chief Risk Officer, MetLife

Current S&P 500 boards
1
Current roles
2
Open-market buys
$0
Open-market sales
$5.2M

Current roles

From Section 16 filings (Forms 3, 4 and 5) in the last 13 months.

Past roles

“Last filing” is the latest Form 3/4/5 for that company, an upper bound on the end date.

None on record since 2016.

Sits alongside

People who currently share a board or management team with this person.

Open-market trades

Purchases and sales reported on Form 4 at S&P 500 companies.

DateCompanyTypeSharesPriceValue
Jun 1, 2026METSale21,312$81.59$1.7M
Dec 13, 2024METSale22,810$82.88$1.9M
Aug 9, 2023METSale9,391$63.18$593K
Aug 19, 2022METSale4,060$67.60$274K
May 11, 2021METSale11,000$64.58$710K

SEC reporting-owner ID (CIK) 1770295 · all filings on EDGAR

Marlene Debel (MET, RJF) | USBoard